Ams Plan
1 known investors
AMS develops next-generation nuclear medicine technologies for Japan's market, including PET diagnostics and radiotherapeutics for precision oncology, alongside a proprietary bedside filtration system for safe radioactive waste management in hospitals.
BiotechHealthtechMedical Devices